NCT00132470View on ClinicalTrials.gov

Treatment With AX200 for Acute Ischemic Stroke

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

March 31, 2007

Conditions
Cerebral Stroke
Interventions
DRUG

AX200 (G-CSF)

Trial Locations (2)

48149

Neurology University of Muenster, Münster

69120

Neurology University of Heidelberg, Heidelberg

Sponsors
All Listed Sponsors
lead

Axaron Bioscience AG

INDUSTRY